Latest news from Baylor College of Medicine
The best way to treat seasonal allergies this spring Mar 25, 2019 Spring welcomes warm weather and sun, but it also is the height of allergy season. Dr. Sanjiv Sur explains the importance of managing seasonal allergy symptoms and the best methods to combat them this year.
Study analyzes family leave policies at schools of public health Mar 21, 2019 A new study examines the parental leave, childcare and breastfeeding policies for faculty and staff at the top 25 schools of public health across the country.
High-fructose corn syrup promotes intestinal tumors in mice Mar 21, 2019 Researchers found consuming a daily modest amount of high-fructose corn syrup can accelerate the growth of intestinal tumors in mouse models of the disease, independently of obesity.
Researchers uncover aspirin’s effects on platelet rich plasma Mar 19, 2019 A collaborative study led by researchers at Baylor College of Medicine explores the effects of aspirin on a new biologic therapy, platelet rich plasma (PRP).
Fourth-year students match for residency training Mar 15, 2019 Fourth-year medical students at Baylor College of Medicine learned where they will conduct their residency training, and their matches revealed a strong focus on primary care fields.
Autism study focuses on underrepresented communities Mar 14, 2019 A new grant to Baylor College of Medicine will build on the ongoing SPARK for Autism research study by focusing on fighting disparities and lack of diversity in autism research.
Study of LDL lowering drug found no increase of adverse events Mar 13, 2019 A study looking at safety of a new drug has found it does not increase overall adverse events or serious adverse events when compared to placebo.
Dr. Hsiao-Tuan Chao named new McNair Scholar Mar 13, 2019 Dr. Hsiao-Tuan Chao has been named the newest McNair Scholar at Baylor. She is the College’s first M.D./Ph.D. McNair Student Scholar Alumni to also be named a McNair Scholar.
Ketamine-based nasal spray to treat depression Mar 12, 2019 A Baylor College of Medicine expert discusses the potential impact of the new ketamine-based treatment recently approved by the FDA, which is being marketed as the first fast-acting depression drug.
Baylor brings genetics conference on autism to Laredo Mar 7, 2019 On Saturday, March 23, Baylor College of Medicine will bring a community conference and resource fair to the Laredo area to provide an educational seminar and support materials for parents of children with autism and developmental disabilities.